A Corpus-Based Analysis of Cohesion in L2 Writing by Undergraduates in Ecuador

In finding out the nature of cohesion in L2 writing, the present study set out to address three research questions: (1) What types of cohesion relations occur in L2 writing at the sentence, paragraph, and whole-text levels? (2) What is the relationship between lexico-grammatical cohesion features and teachers’ judgements of writing quality? (3) Do expectations of cohesion suggested by the CEFR match what is found in student writing? To answer those questions, a corpus of 240 essays and 240 emails from college- level students learning English as a foreign language in Ecuador enabled the analysis of cohesion. Each text included the scores, or teachers’ judgements of writing quality aligned to the upper-intermediate level (or B2) as proposed by the Common European Framework of Reference for learning, teaching, and assessing English as a foreign language. Lexical and grammatical items used by L2 students to build relationships of meaning in sentences, paragraphs, and the entire text were considered to analyse cohesion in L2 writing. Utilising Natural Language Processing tools (e.g., TAACO, TextInspector, NVivo), the analysis focused on determining which cohesion features (e.g., word repetition/overlap, semantical similarity, connective words) predicted the teachers’ judgements of writing quality in the collected essays and emails. The findings indicate that L2 writing is characterised by word overlap and synonyms occurring at the paragraph level and, to a lesser degree, cohesion between sentences and the entire text (e.g., connective words). Whilst these cohesion features positively and negatively predicted the teachers’ scores, a cautious interpretation of these findings is required, as many other factors beyond cohesion features must have also influenced the allocation of scores in L2 writing

Diet of Lontra longicaudis (Olfers, 1818) (Carnivora: Mustelidae) in three limnic systems in Southern Rio Grande do Sul State, Brazil

The aim of the present work was to study the diet of Lontra longicaudis in three limnic systems (anthropogenic shallow lakes, pluvial channel and coastal stream) in Rio Grande do Sul State coastal plain, southern Brazil. Fishes were the most consumed item in all the three systems, being Mugilidae the most representative family in the pluvial channel and coastal stream and Cichlidae in the shallow lakes. Other identified items were mollusks, insects, crustaceans, amphibians, reptiles, birds and mammals and vegetal fragments. The high frequency of birds in the shallow lakes was remarkable, considering the lower frequencies of this item in previous investigations on the species diet. There was a high frequency of swamp eels (Synbranchidae, Synbranchus marmoratus) in the pluvial channel and shallow lakes, which were usually absent or found in low frequencies in previous studies

Comparison of fatal or irreversible events with extended-duration betrixaban versus standard dose enoxaparin in acutely Ill medical patients: An APEX trial substudy

Background-Extended-duration betrixaban showed a significant reduction in venous thromboembolism in the APEX trial (Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study). Given the variable clinical impact of different efficacy and safety events, one approach to assess net clinical outcomes is to include only those events that are either fatal or cause irreversible harm. Methods and Results-This was a post hoc analysis of the APEX trial-a multicenter, double-blind, randomized controlled trial comparing extended-duration betrixaban versus standard-of-care enoxaparin. A composite of all fatal or irreversible safety (fatal bleeding or intracranial hemorrhage) and efficacy events (cardiopulmonary death, myocardial infarction, pulmonary embolism, and ischemic stroke) was evaluated in a time-to-first event analysis. In patients with positive D-dimer results, betrixaban reduced fatal or irreversible events at 35 to 42 days (4.80% versus 3.54%; hazard ratio, 0.73; absolute risk reduction, 1.26%; number needed to treat, 79 [P=0.033]) and at study end at 77 days (6.27% versus 4.36%; hazard ratio, 0.70; absolute risk reduction, 1.91%; number needed to treat, 52 [P=0.005]) versus enoxaparin. In all patients, betrixaban reduced fatal or irreversible events at 35 to 42 days (4.08% versus 2.90%; hazard ratio, 0.71; absolute risk reduction, 1.18%; number needed to treat, 86 [P=0.006]) and 77 days (5.17% versus 3.64%; hazard ratio, 0.70; absolute risk reduction, 1.53%; number needed to treat, 65 [P=0.002]). Conclusions-Among hospitalized medically ill patients, extended-duration betrixaban demonstrated an 48 30% reduction in fatal or irreversible ischemic or bleeding events compared with standard-duration enoxaparin. A total of 65 patients would require treatment with betrixaban to prevent 1 fatal or irreversible event versus enoxaparin